Publication:
18F-fluorodeoxyglucose positron emission tomography / computed tomography in the diagnosis of secondary malignancies in a patient with Hodgkin lymphoma

dc.contributor.authorPantić, Nikola (57221630977)
dc.contributor.authorStojiljković, Milica (55217486100)
dc.contributor.authorGrujičić, Lenka (59909503300)
dc.contributor.authorŠaranović, Dragana Šobić (57234390300)
dc.contributor.authorArtiko, Vera (55887737000)
dc.date.accessioned2025-06-12T11:37:43Z
dc.date.available2025-06-12T11:37:43Z
dc.date.issued2025
dc.description.abstractIntroduction The incidence of a second cancer among patients who have been treated for Hodgkin lymphoma (HL) is higher than the incidence of cancer in the general population.18F-fluorodeoxyglucose (18F-FDG) positron emission tomography / computed tomography is used in the evaluation of a number of malignancies. The aim of the article is to emphasize the importance of including a second primary cancer as a differential diagnosis among patients at risk. Case outline We present a case of a patient diagnosed with two separate malignancies almost two decades after the treatment of HL. Conclusion In patients previously treated for HL, a biopsy of lesions that show high 18F-FDG uptake should be advised, particularly if the location of the lesion is unusual for the primary diagnosis. © 2025, Serbia Medical Society. All rights reserved.
dc.identifier.urihttps://doi.org/10.2298/SARH241111031P
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-105005894142&doi=10.2298%2fSARH241111031P&partnerID=40&md5=8a1049d8e59b8d7f49bdbc02cf64a1eb
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/612
dc.subjectchemo-therapy
dc.subjectlymphoma, Hodgkin
dc.subjectpositron emission tomography
dc.subjectradiation therapy
dc.subjectsecond primary malignancy
dc.title18F-fluorodeoxyglucose positron emission tomography / computed tomography in the diagnosis of secondary malignancies in a patient with Hodgkin lymphoma
dspace.entity.typePublication

Files